With a painful two-year restructuring behind it - and its pharmaceutical franchise officially on the mend - German drug and chemicals group Merck KGAA now plans to boost its biopharma lab business by buying U.S.-based MilliporeSigma for $17 billion in cash.
Sigma-Aldrich is a life science and high technology company with more than 9,600 employees and operations in 40 countries. The...